常用名 | 托伐普坦 | CAS号 | 150683-30-0 |
---|---|---|---|
价格 | ¥1166.0/10mg ¥356.0/1mg ¥3886.0/50mg ¥2156.0/25mg | 纯度 | 98.0% |
备货期 | 2天 | 库存 | 询单 |
产品详情(用途,包装等)
用途: Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.IC50 value: 1.28 uM (inhibition of AVP-induced platelet aggregation)Target: vasopressin receptor 2Tolvaptan (OPC-41061) is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. Tolvaptan (OPC-41061) is used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan (OPC-41061) is also in fast-track clinical trials for polycystic kidney disease. Treatment with t tolvaptan (OPC-41061) causes rapid and sustained body weight reductions concurrent with increases in urine output, improves and/or normalizes serum sodium in hyponatremic patients, reduces signs and symptoms of congestion and increases thirst. However, tolvaptan (OPC-41061) has not been shown to decrease heart failure re-hospitalization or mortality. As an adjunct to standard therapy, tolvaptan (OPC-41061) is unique in that it is virtually the only novel agent tested in patients hospitalized for acute heart failure syndrome (AHFS) to reach its primary end point for short-term efficacy without causing deleterious side effects. 物理化学性质: CAS号:150683-30-0 常用中文名:托伐普坦 常用英文名:Tolvaptan 分子式:C26H25ClN2O3 分子量:448.941 密度:1.3±0.1 g/cm3 沸点:594.4±50.0 °C at 760 mmHg 熔点:219-222°C 闪点:313.3±30.1 °C 储存条件:Refrigerator |